The role of L1CAM as predictor of poor prognosis in stage I endometrial cancer: a systematic review and meta-analysis
Archives of Gynecology and Obstetrics · 2023
DOI: 10.1007/s00404-023-07149-8 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Archives of Gynecology and Obstetrics, 2023. Verfasst von Andrea Giannini und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical and Surgical Sciences and Translational Medicine, PhD Course in "Translational Medicine and Oncology", Sapienza University, Rom…. Hauptthemen laut MEDLINE: Endometrial Neoplasms, Neural Cell Adhesion Molecule L1. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 52 Literaturangaben.
Abstract (Originalsprache)
INTRODUCTION: Molecular and genomic profiling in endometrial cancer is increasing popularity. L1 cell adhesion molecule (L1CAM) is frequently mutated in endometrial cancer. In this paper, we aim to evaluate the prognostic role of L1CAM in patients with stage I endometrial cancer. METHODS: We performed a systematic review and meta-analysis searching in PubMed (MEDLINE), EMBASE, and Web of Science database to identify studies reporting the expression of L1CAM in endometrial cancer. The primary endpoint measure was to assess and evaluate the impact of L1CAM on survival outcomes. This study was performed according to the Preferred Reporting Items for Systematic review and Meta-Analysis Protocols (PRISMA-P) statement. RESULTS: Five studies were included. The pooled results suggested that L1CAM expression influences survival outcomes in stage I endometrial cancer. High L1CAM expression correlated with worse disease-free survival (HR 4.11, 95% CI 1.02-16.59, p = 0.047) and overall survival (HR 3.62, 95% CI 1.32-9.31, p = 0.012). High L1CAM level was also associated with a more aggressive FIGO grade and with older age. CONCLUSION: This systematic review supported that L1CAM have a prognostic role in stage I endometrial cancer, thus providing a potential useful tool for tailoring the need of adjuvant therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical and Surgical Sciences and Translational Medicine, PhD Course in "Translational Medicine and Oncology", Sapienza University, Rome, Italy. andrea.giannini@uniroma1.it.
- Department of Medical and Surgical Sciences and Translational Medicine, PhD Course in "Translational Medicine and Oncology", Sapienza University, Rome, Italy.
- Dipartimento Scienze della Salute della Donna, del Bambino, e di Sanità Pubblica, Ginecologia Oncologica, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
- Gynecologic Oncology Unit, Department of Experimental Clinical Oncology, IRCSS-Regina Elena National Cancer Unit Institute, Rome, Italy.
- Scientific Direction, IRCCS "Regina Elena" National Cancer Institute, Rome, Italy.
- Department of Maternal and Child Health and Urological Sciences, Sapienza University of Rome, Policlinico Umberto I, Rome, Italy.
ORCID-Profile: Andrea Giannini
Zitieren
APA
Giannini, A., D'Oria, O., Corrado, G., Bruno, V., Sperduti, I., Bogani, G., Laganà, A. S., Chiantera, V., Caserta, D., & Vizza, E. (2023). The role of L1CAM as predictor of poor prognosis in stage I endometrial cancer: a systematic review and meta-analysis. Archives of Gynecology and Obstetrics. https://doi.org/10.1007/s00404-023-07149-8
Vancouver
Giannini A, D'Oria O, Corrado G, Bruno V, Sperduti I, Bogani G, et al. The role of L1CAM as predictor of poor prognosis in stage I endometrial cancer: a systematic review and meta-analysis. Archives of Gynecology and Obstetrics. 2023. doi:10.1007/s00404-023-07149-8
BibTeX
@article{Giannini2023,
author = {Giannini, Andrea and D'Oria, Ottavia and Corrado, Giacomo and Bruno, Valentina and Sperduti, Isabella and Bogani, Giorgio and Laganà, Antonio Simone and Chiantera, Vito and Caserta, Donatella and Vizza, Enrico},
title = {The role of L1CAM as predictor of poor prognosis in stage I endometrial cancer: a systematic review and meta-analysis},
journal = {Archives of Gynecology and Obstetrics},
year = {2023},
doi = {10.1007/s00404-023-07149-8}
}
EUVIMED